Cargando…

What to Expect from COVID-19 and from COVID-19 Vaccine for Expecting or Lactating Women

Recent studies identified pregnancy as a high-risk condition for the development of maternal-fetal complications in the case of the SARS-CoV-2 infection. Therefore, the scientific community is now considering pregnant women a “fragile” category that should be vaccinated with high priority. The numbe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gangi, Roberta, Corrias, Angelica, Pintus, Roberta, Marcialis, Maria Antonietta, Fanos, Vassilios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228525/
https://www.ncbi.nlm.nih.gov/pubmed/35736656
http://dx.doi.org/10.3390/pediatric14020034
_version_ 1784734500183343104
author Gangi, Roberta
Corrias, Angelica
Pintus, Roberta
Marcialis, Maria Antonietta
Fanos, Vassilios
author_facet Gangi, Roberta
Corrias, Angelica
Pintus, Roberta
Marcialis, Maria Antonietta
Fanos, Vassilios
author_sort Gangi, Roberta
collection PubMed
description Recent studies identified pregnancy as a high-risk condition for the development of maternal-fetal complications in the case of the SARS-CoV-2 infection. Therefore, the scientific community is now considering pregnant women a “fragile” category that should be vaccinated with high priority. The number of pregnant women undergoing hospitalization since summer 2021, including Intensive Care Unit admission, is growing, as well as the risk of preterm birth. Evidence from both animals and humans suggest that, similarly to other vaccines routinely administered in pregnancy, COVID-19 vaccines are not crossing the placenta, do not increase the risk of miscarriage, preterm birth, stillbirth, the birth of small gestational age neonates, as well as the risk of congenital abnormalities. To date, the World Health Organization and scientific literature are promoting and encouraging the vaccination of all pregnant and lactating women. The aim of our narrative review is to present the available literature regarding this issue with the aim to provide appropriate answers to the most frequent requests, doubts, and fears that have led many expecting and lactating women not to become vaccinated during this pandemic period.
format Online
Article
Text
id pubmed-9228525
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92285252022-06-25 What to Expect from COVID-19 and from COVID-19 Vaccine for Expecting or Lactating Women Gangi, Roberta Corrias, Angelica Pintus, Roberta Marcialis, Maria Antonietta Fanos, Vassilios Pediatr Rep Review Recent studies identified pregnancy as a high-risk condition for the development of maternal-fetal complications in the case of the SARS-CoV-2 infection. Therefore, the scientific community is now considering pregnant women a “fragile” category that should be vaccinated with high priority. The number of pregnant women undergoing hospitalization since summer 2021, including Intensive Care Unit admission, is growing, as well as the risk of preterm birth. Evidence from both animals and humans suggest that, similarly to other vaccines routinely administered in pregnancy, COVID-19 vaccines are not crossing the placenta, do not increase the risk of miscarriage, preterm birth, stillbirth, the birth of small gestational age neonates, as well as the risk of congenital abnormalities. To date, the World Health Organization and scientific literature are promoting and encouraging the vaccination of all pregnant and lactating women. The aim of our narrative review is to present the available literature regarding this issue with the aim to provide appropriate answers to the most frequent requests, doubts, and fears that have led many expecting and lactating women not to become vaccinated during this pandemic period. MDPI 2022-05-30 /pmc/articles/PMC9228525/ /pubmed/35736656 http://dx.doi.org/10.3390/pediatric14020034 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gangi, Roberta
Corrias, Angelica
Pintus, Roberta
Marcialis, Maria Antonietta
Fanos, Vassilios
What to Expect from COVID-19 and from COVID-19 Vaccine for Expecting or Lactating Women
title What to Expect from COVID-19 and from COVID-19 Vaccine for Expecting or Lactating Women
title_full What to Expect from COVID-19 and from COVID-19 Vaccine for Expecting or Lactating Women
title_fullStr What to Expect from COVID-19 and from COVID-19 Vaccine for Expecting or Lactating Women
title_full_unstemmed What to Expect from COVID-19 and from COVID-19 Vaccine for Expecting or Lactating Women
title_short What to Expect from COVID-19 and from COVID-19 Vaccine for Expecting or Lactating Women
title_sort what to expect from covid-19 and from covid-19 vaccine for expecting or lactating women
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228525/
https://www.ncbi.nlm.nih.gov/pubmed/35736656
http://dx.doi.org/10.3390/pediatric14020034
work_keys_str_mv AT gangiroberta whattoexpectfromcovid19andfromcovid19vaccineforexpectingorlactatingwomen
AT corriasangelica whattoexpectfromcovid19andfromcovid19vaccineforexpectingorlactatingwomen
AT pintusroberta whattoexpectfromcovid19andfromcovid19vaccineforexpectingorlactatingwomen
AT marcialismariaantonietta whattoexpectfromcovid19andfromcovid19vaccineforexpectingorlactatingwomen
AT fanosvassilios whattoexpectfromcovid19andfromcovid19vaccineforexpectingorlactatingwomen